Health
Is mRNA Tech the Future of Flu Shots? Report – The Quint
While Moderna, Pfizer and Sanofi have, in recent months, initiated Phase 1 trials of mRNA-based seasonal flu vaccine candidates,…
The flexibility and speed of mRNA vaccine production also means that drug makers could wait longer to begin manufacturing starting production in May, say, instead of February, for the northern hemisphere.
This would enable them to make more informed decisions…
Continue Reading